DD vs SRTS · P/E 127, rev $12.39B vs P/E 42, rev $41.8M
Dupont De Nemours Inc (DD) versus Sensus Healthcare Inc (SRTS) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Sensus Healthcare Inc (SRTS) is a medical devices company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported SRTS revenue for 2024-12-31 was $41.8M. Net income was $6.6M. Revenue was up 71.3% from 2023-12-31 to 2024-12-31. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
DD currently screens at market cap $19.61B and trailing P/E 127.4. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
Not investment advice. Open the DD and SRTS stock pages for the full models.
Not investment advice.